Showing 2,041 - 2,060 results of 122,261 for search '(( 2 e decrease ) OR ( 5 ((((we decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 2.08s Refine Results
  1. 2041

    HGDP data show that T2D risk allele frequencies decrease from Sub-Saharan Africa through Europe to East Asia. by Rong Chen (29176)

    Published 2012
    “…A similar pattern was observed in the remaining five T2D risk alleles in <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1002621#pgen.1002621.s002" target="_blank">Figure S2</a>. …”
  2. 2042

    Image4_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

    Published 2024
    “…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”
  3. 2043

    Image2_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

    Published 2024
    “…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”
  4. 2044

    Image6_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

    Published 2024
    “…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”
  5. 2045

    Image1_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

    Published 2024
    “…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”
  6. 2046

    Image3_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

    Published 2024
    “…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”
  7. 2047

    Image7_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

    Published 2024
    “…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”
  8. 2048

    Table1_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.xlsx by Mohammad Arif Rahman (8267352)

    Published 2024
    “…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”
  9. 2049
  10. 2050

    Ovariectomy (OVX) induced decrease in hexokinase expression and activity: prevention by 17β-estradiol. by Fan Ding (302565)

    Published 2013
    “…<p>A. In female 3×TgAD brains, OVX induced a significant decrease in protein expression of hexokinase 2 (*, P<0.05, bars represent mean value±SEM, n = 5−6), which was partially prevented by E2 treatment. …”
  11. 2051

    17- and 19-Electron Complexes [Fe<sup>III</sup>(η<sup>5</sup>-C<sub>5</sub>R<sub>5</sub>)(S<sub>2</sub>CNMe<sub>2</sub>)L]<sup><i>n</i>+</sup> (<i>n</i> = 1, 0):  Electronic Struct... by Marie-Hélène Delville-Desbois (2995521)

    Published 1996
    “…The cations were reduced to isostructural neutral Fe<sup>II</sup> complexes using 1 equiv of [Fe<sup>I</sup>Cp(C<sub>6</sub>Me<sub>6</sub>)] in THF or oxidized to the robust green 18e Fe<sup>IV</sup> complex [Fe<sup>IV</sup>(η<sup>5</sup>-C<sub>5</sub>Me<sub>5</sub>)(η<sup>2</sup>-S<sub>2</sub>CNMe<sub>2</sub>)<sub>2</sub>]<sup>+</sup>PF<sub>6</sub><sup>-</sup>, <b>9<sup>+</sup>PF<sub>6</sub><sup>-</sup></b>, using Na<sup>+</sup>dtc<sup>-</sup>·2H<sub>2</sub>O. …”
  12. 2052

    Table_1_v2_A long waiting time from diagnosis to treatment decreases the survival of non-small cell lung cancer patients with stage IA1: A retrospective study.docx by Bin Liu (5899)

    Published 2022
    “…After adjusting for other confounders, the waiting time was identified as an independent prognostic factor.</p>Conclusions<p>A long waiting time before treatment may decrease the survival of stage IA1 NSCLC patients. …”
  13. 2053
  14. 2054
  15. 2055

    Image1_Reduction of kinesin I heavy chain decreases tau hyperphosphorylation, aggregation, and memory impairment in Alzheimer’s disease and tauopathy models.jpg by Karthikeyan Selvarasu (14004867)

    Published 2022
    “…We also found that the knockdown and knockout (KO) of KIFf5B significantly decreased the tau stability, and overexpression of KIF5B in KIF5B-KO cells significantly increased the expression of phosphorylated and total tau levels. …”
  16. 2056

    SERCA is required for Ca<sup>2</sup>+ transients at E5.5. by Matthew J. Stower (22379321)

    Published 2025
    “…<p>To test the requirement of endoplasmic reticulum (ER) for Ca<sup>2+</sup> dynamics at E5.5, GCaMP6f embryos were treated with SERCA inhibitors, and the total number of Ca<sup>2+</sup> transients measured. …”
  17. 2057
  18. 2058
  19. 2059
  20. 2060